Truscreen GroupASX:TRU Market Cap is A$13.33 Mil as of Jun. 29, 2026. The stock has 6 warning signs investors should review. Among 867 Medical Devices & Instruments companies, Truscreen Group ranks worse than 85.81% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Truscreen Group's share price for the quarter that ended in Mar. 2025 was A$0.025688. Truscreen Group's Shares Outstanding (EOP) for the quarter that ended in Mar. 2025 was 589.28 Mil. Therefore, Truscreen Group's market cap for the quarter that ended in Mar. 2025 was A$15.14 Mil.
Truscreen Group's quarterly market cap
declined
from Mar. 2024 (A$11.72 Mil) to Sep. 2024 (A$11.17 Mil) but then
increased
from Sep. 2024 (A$11.17 Mil) to Mar. 2025 (A$15.14 Mil).
Truscreen Group's annual market cap
increased
from Mar. 2024 (A$11.72 Mil) to Mar. 2025 (A$15.14 Mil) but then
declined
from Mar. 2025 (A$15.14 Mil) to Mar. 2026 (A$10.19 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Truscreen Group's Enterprise Value for Today is A$12.30 Mil.
Truscreen Group (ASX:TRU) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Truscreen Group Market Cap Related Terms
Truscreen Group Market Cap Historical Data
* Premium members only.
The historical data trend for Truscreen Group's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Truscreen Group's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Truscreen Group Market Cap vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Truscreen Group's Market Cap distribution charts can be found below:
* The bar in red indicates where Truscreen Group's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Truscreen Group's Market Cap for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Truscreen Group (ASX:TRU) has a Market Cap of A$13.33 Mil as of Jun. 29, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Truscreen Group and its competitors. According to the industry distribution chart, Truscreen Group ranks #744 out of 867 companies in the Medical Devices & Instruments industry, placing it in the top 85.8%.
Is Truscreen Group's Market Cap too high?
Truscreen Group's current Market Cap is A$13.33 Mil. Based on the distribution chart, Truscreen Group ranks #744 out of 867 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers.
How does Truscreen Group's Market Cap compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Truscreen Group ranks #744 out of 867 companies for Market Cap. This places Truscreen Group in the lower half of its industry. The industry median Market Cap is 117.03. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Medical Devices & Instruments company?
The median Market Cap among Medical Devices & Instruments companies is 117.03, based on 867 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Truscreen Group and its competitors. For the Medical Devices & Instruments industry, the median Market Cap is 117.03 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Truscreen Group's current Market Cap is A$13.33 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Truscreen Group stock overvalued right now?
Based on GuruFocus' analysis, Truscreen Group (ASX:TRU) is currently considered Significantly Overvalued. The stock's GF Value™ is A$0.01, compared to a current price of A$0.01 — trading 40% above its estimated fair value. The current Market Cap is A$13.33 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Truscreen Group (ASX:TRU), the current Market Cap is A$13.33 Mil as of Jun. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Truscreen Group Ltd is a medical device company. The company manufactures and distributes the Truscreen Cervical Cancer screening device, which comprises a medical device and process designed to detect the presence in real-time of precancerous and cancerous tissue on the cervix. The product utilizes technology to detect the pre-cancerous change, or cervical intraepithelial neoplasia (CIN), by optical and electrical measurements of cervical tissue. Geographically, the company operates its business in New Zealand, Mexico, China, Russia, Zimbabwe, Vietnam, and other countries. Maximum revenue is generated from China.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:TRU has been successfully added to your 